Creating a new treatment for Alzheimer's disease
Development of a Novel Alzheimer's Disease Therapeutic
This study is exploring a new way to help people with Alzheimer's by using tiny particles to deliver a safe, existing medication that may reduce brain inflammation and improve memory, and they will first test it in the lab and on animals before considering it for human trials.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aphios Corporation NIH-funded |
| Lab location | 1 site (Woburn, United States) |
| Project ID | NIH-10920778 on NIH RePORTER |
What this research studies
This research focuses on developing a novel therapeutic approach for Alzheimer's disease by targeting inflammation in the brain. The team will create nanoparticles that encapsulate an FDA-approved drug aimed at the CCR5 receptor, which is linked to memory issues in aging. They will test these nanoparticles in laboratory models to assess their effectiveness in reducing brain inflammation and improving cognitive function. The research will progress through various phases, including in vitro studies and animal testing, to ensure safety and efficacy before potential human trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are experiencing symptoms of Alzheimer's disease.
Not a fit: Patients with other forms of dementia or those who are not diagnosed with Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment that alleviates symptoms of Alzheimer's disease and improves memory function.
How similar studies have performed: Previous research has shown promise in targeting inflammation in Alzheimer's disease, but this specific approach using nanoparticles is relatively novel.
Where this research is happening
Woburn, United States
- Aphios Corporation — Woburn, United States (Active)
Researchers
- Principal investigator: Castor, Trevor P. — Aphios Corporation
- Study coordinator: Castor, Trevor P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.